252 related articles for article (PubMed ID: 21620502)
1. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
[TBL] [Abstract][Full Text] [Related]
2. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
3. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
4. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
7. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
10. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
Rades D; Raabe A; Bajrovic A; Alberti W
Strahlenther Onkol; 2004 Mar; 180(3):144-7. PubMed ID: 14991201
[TBL] [Abstract][Full Text] [Related]
11. [Whole brain radiation with supplementary boost for patients for unique brain metastasis from a primitive lung cancer].
Lévy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C; Assouline A
Cancer Radiother; 2011 Aug; 15(5):426-9. PubMed ID: 21757387
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
14. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
15. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
16. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
18. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
19. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
